PEOPLE - Cambridge Heart makes appointment:
This article was originally published in Clinica
Executive Summary
Developer of products for the non-invasive diagnosis of cardiac disease Cambridge Heart (Bedford, Massachusetts) has promoted Jeffrey Kangan to president and CEO, replacing David Chazanovitz, who has resigned. Also, Reed Malleck replaces Mr Kangan as chairman of the audit committee, who has resigned; and Laurence Blumberg - managing director and one of the firm's founders - has joined the company's board of directors.